Gunderson Dettmer Stough Villeneuve Franklin & Hachigian represented Muna Therapeutics in the transaction.Muna Therapeutics, a biotechnology company focused on developing innovative therapeutics for neurodegenerative diseases, announced…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
